2:1 allocation [General Sta­tis­tics]

posted by msmnainar – India, 2021-06-23 16:49 (33 d 08:41 ago) – Posting: # 22428
Views: 278

Hi Helmut,

Thanks for your detailed explanation.

» » Note: The 2:1 randomization is mainly due to transition arm.
» What do you mean by that?

Transition arm is in general re-randomization at certain week after efficacy evaluation (FDA requirement).

Basically, 1:1 randomization allocation would lead to a larger sample size for subjects transitioning from Reference to Test, which would allow for detecting differences in immunogenicity and safety.

Sundar. M

Complete thread:

 Admin contact
21,589 posts in 4,512 threads, 1,530 registered users;
online 3 (0 registered, 3 guests [including 2 identified bots]).
Forum time: Tuesday 01:30 CEST (Europe/Vienna)

The great tragedy of Science – the slaying
of a beautiful hypothesis by an ugly fact.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz